Exp Clin Endocrinol Diabetes 2000; Vol. 108(8): 513-514
DOI: 10.1055/s-2000-11006
Short Communication

© Johann Ambrosius Barth

PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations

M. Ocker1 , R. Sachse1 , A. Rico1 , J. Hensen2
  • 1 Division of Endocrinology and Metabolism, Department of Medicine 1, Friedrich-Alexander-University Erlangen-Nürnberg, Germany
  • 2 Department of Medicine, Klinikum Hannover-Nordstadt, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Summary:

Little is known about the pathogenesis and etiology of benign tumors of the adrenal cortex. A variety of cellular oncogenes and tumor suppressor genes has been studied so far. The role of K-ras in this process is not yet clearly understood. Recent findings suggest a strong influence of mutated K-ras in the pathogenesis of adrenal adenomas ([Lin et al., 1998]). Therefore we studied 40 human adrenal tumors for mutations in the coding region of the cellular proto-oncogene K-ras by PCR-SSCP (Single-strand conformation polymorphism) analysis. We did not identify any activating mutation in the coding region of the K-ras gene. We conclude that activating mutations of the K-ras gene are not a major cause for the development of adrenal adenomas, if at all.

References

  • 1 Bos J L. Ras oncogenes in human cancer: A review.  Cancer Res. 49 4682-4689 1989; 
  • 2 Gicquel C, Bertagna X, LeBouc Y. Recent advances in the pathogenesis of adrenocortical tumours.  Eur J Endocrinol. 133 133-144 1995; 
  • 3 Hayashi K, Yandell D W. How sensitive is PCR-SSCP?.  Human Mutation. 2 338-346 1993; 
  • 4 Hayashi K. PCR-SSCP: A method for detection of mutations.  GATA. 9 73-79 1992; 
  • 5 Higaki J, Miya A, Miki T, Morishita R, Mikami H, Takai S, Ogihara T. Contribution of the activation of the ras oncogene to the evolution of aldosterone- and renin-secreting tumors.  J Hypertens. 9 135-137 1991; 
  • 6 Lin S R, Tsai J H, Yang Y C, Lee S C. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.  Br J Cancer. 77(7) 1060-1065 1998; 
  • 7 Moul J W, Bishoff J T, Theune S M, Chang E H. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.  J Urol. 149 1389-1394 1993; 
  • 8 Nusko G, Sachse R, Mansmann U, Wittekind C, Hahn E G. K-ras-2 gene mutations as predictors of metachronous colorectal adenomas.  Scand J Gastroenterol. 32 1035-1041 1997; 
  • 9 Ohgaki H, Kleihues P, Heitz P U. p53 mutations in sporadic adrenocortical tumors.  Int J Cancer. 54 408-410 1993; 
  • 10 Reincke M, Allolio B. Molecular biology of incidentally diagnosed adrenal gland space-occupying lesin.  Zentralbl Chir. 122 430-437 1997; 
  • 11 Yashiro T, Hara H, Fulton N C, Obara T, Kaplan E L. Point mutations of ras genes in human adrenal cortical tumors: Absence in adrenocortical hyperplasia.  World J Surg. 18 455-461 1994; 

Prof. Dr. J. Hensen

Department of Medicine

Klinikum Hannover-Nordstadt

Haltenhoffstr. 41

D-30167 Hannover

Germany

Phone: + 49-511-9701290

Fax: + 49-511-9701738

Email: Johannes.hensen@t-online.de